Changing trends in patient decisions concerning genetic amniocentesis

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 5, 2000, Pages 1018-1020

  Kocun, C C ^a   Harrigan, John T ^a   Canterino, J C ^b   Feld, S M ^a   Fernandez, C O ^b  

^a MERIDIAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Amniocentesis; Genetic testing

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AMNIOCENTESIS; ARTICLE; DECISION MAKING; DOWN SYNDROME; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PREGNANCY; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; SCREENING;

EID: 0034079995     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.105442     Document Type: Article

References (11)

1. 1. Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 1992;327:588-93.
2. 2. Palomaki GE, Knight GJ, McCarthy JE, Haddow JE, Donhowe JM. Maternal serum screening for Down syndrome in the United States: a 1995 survey. Am J Obstet Gynecol 1997; 176:1046-51.
3. 3. O'Leary P, Bower C, Murch A, Crowhurst J, Goldblatt J. The impact of antenatal screening for Down syndrome in Western Australia: 1980-1994. Aust N Z J Obstet Gynaecol 1996; 36:385-8.
4. 4. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 1994;330:1114-8.
5. 5. Sheldon TA, Simpson J. Appraisal of a new scheme for prenatal screening for Down's syndrome. BMJ 1991;302:1133-6.
6. 6. Wenstrom KD, Desai R, Owen J, DuBard MB, Boots L. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women ≥35 years old. Am J Obstet Gynecol 1995;173:1287-92.
7. 7. Bahado-Singh RO, Oz AU, Kovanci E, Deren O, Copel J, Baumgarten A, et al. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age. Am J Obstet Gynecol 1998;179: 1627-31.
8. 8. Bahado-Singh R, Deren O, Oz U, Tan A, Hunter D, Copel J, et al. An alternative for women initially declining genetic amniocentesis: individual Down syndrome odds on the basis of maternal age and multiple sonographic markers. Am J Obstet Gynecol 1998;179:514-9.
9. 9. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995;172:837-44.
10. 10. Priest JH, Fitzgerald JM, Haag MM, Streets K, Vanisko M, Johnson JP. Acceptance of amniocentesis by women in the state of Montana (USA) who are screen positive for Down's syndrome. J Med Screen 1998;5:178-82.
11. 11. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304:867-9.